News

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...
Session ID: 2025-07-03:9a61974b939236f32b419e45 Player Element ID: V3f69f3ef_05ce_43e7_acbe_c951afabbbb5_6374131301112 ...
Meralco Power Academy (MPA) and Mindanao State University-General Santos (MSU-GenSan) teamed up to promote education, training and research initiatives in the energy sector. Officials recently signed ...
The FDA’s June 9, 2025, approval of clesrovimab (Enflonsia; Merck) to prevent respiratory syncytial virus (RSV) in infants could have potential ripple effects of RSV prevention—not only in reducing ...
John Yudichak President of Luzerne County Community College college talks about the new program that offers people a chance to earn a four-year degree in teaching for less than $30,000 without ...
September 17, 2023. [File, Standard] Prof Simon Gicharu, founder and chairman of MKU, commended the Foundation for its efforts in ensuring access to education for disadvantaged children.
Only a small percentage—10.4%—was nonfrail. Severe RSV Outcomes The researchers found that severe cases of RSV were more common among patients aged 75 to 84 years (27.4%) and 85 years and older (27.7% ...
Sony Interactive Entertainment has announced Climate Station, a free educational application for PlayStation 5 and PlayStation VR2, developed in cooperation with the United Nations Playing for the … ...
The committee will also vote on use of RSV vaccines, but not the next COVID-19 boosters, as originally expected, according to the agenda. Other expected votes were also removed.
The power of protection. There's encouraging news for parents. The number of Australian babies admitted to hospital with RSV has nearly halved compared to the same period last year, according to the ...
This week, the National Museum of the Pacific War invites the public to attend three free events to spotlight lesser-known stories and contributions to the war effort in World War II.
HealthDay News — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants. The U.S. Food and Drug Administration ...